Chemically modified peanut extract shows increased safety while maintaining immunogenicity

著录项

• 来源
  《Allergy》 |2019年第5期|共10页
• 作者

  van der Kleij Hanneke P. M.; Warmenhoven Hans J. M.; van Ree Ronald; Versteeg Serge A.; Pieters Raymond H. H.; Dreskin Stephen C.; Knulst Andre C.; van Hoffen Els; Opstelten Dirk Jan E.; Koppelman Stef J.; Smit Joost J.;

  展开▼
• 作者单位

  HAL Allergy BV Leiden Netherlands;

  HAL Allergy BV Leiden Netherlands;

  Univ Amsterdam Acad Med Ctr Dept Expt Immunol Amsterdam Netherlands;

  Univ Amsterdam Acad Med Ctr Dept Expt Immunol Amsterdam Netherlands;

  Univ Utrecht Inst Risk Assessment Sci Immunotoxicol Utrecht Netherlands;

  Univ Colorado Denver Sch Med Dept Med Div Allergy &

  Clin Immunol Aurora CO USA;

  Univ Utrecht Univ Med Ctr Utrecht Dept Dermatol Allergol Utrecht Netherlands;

  Univ Utrecht Univ Med Ctr Utrecht Dept Dermatol Allergol Utrecht Netherlands;

  HAL Allergy BV Leiden Netherlands;

  Univ Nebraska Lincoln NE USA;

  Univ Utrecht Inst Risk Assessment Sci Immunotoxicol Utrecht Netherlands;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 医学免疫学;
• 关键词

  immunogenicity; modification; mouse model; peanut allergy; subcutaneous immunotherapy;

  机译：免疫原性;修改;小鼠模型;花生过敏;皮下免疫疗法;